Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.920
-0.020 (-1.03%)
At close: May 12, 2025, 4:00 PM
2.050
+0.130 (6.77%)
After-hours: May 12, 2025, 5:47 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $53.35 million as of May 12, 2025. Its market cap has increased by 7.14% in one year.
Market Cap
53.35M
Enterprise Value
43.76M
1-Year Change
7.14%
Ranking
Category
Stock Price
$1.92
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $53.35M, a decrease of -57.20%. That is a compound annual growth rate of -18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 53.35M | -6.88% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |